Thymidylate synthase inhibitors in colorectal cancer
Cassidy, J.
Seminars in Oncology 27(5 Suppl 10: 83-87
2000
ISSN/ISBN: 0093-7754 PMID: 11049037 Document Number: 523437
Document emailed within 1 workday
Related Documents
Sanguedolce, R.; Vultaggio, G.; Sanguedolce, F.; Modica, G.; Li Volsi, F.; Diana, G.; Guereio, G.; Bellanca, L.; Rausa, L. 1998: The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer Anticancer Research 18(3a): 1515-1520Fernández-Contreras, M.ía.-E.ón.; Jiménez De Ayala, B.; García De Paredes, M.ía.-L.; Velasco, A.; Majano, P.L.; Palacios, J.é; Gamallo, C. 2004: Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil International Journal of Oncology 25(4): 877-885
Nagano, H.; Ichikawa, W.; Simizu, M.; Shirota, Y.; Nihei, Z. 2004: Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 889-892
Ochiai, T.; Sugitani, M.; Nishimura, K.; Noguchi, H.; Watanabe, T.; Sengoku, H.; Komiyama, H.; Okano, M. 2002: Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(3): 413-420
Ishibashi, K.; Okada, N.; Ishiguro, T.; Kuwabara, K.; Ohsawa, T.; Yokoyama, M.; Kumamoto, K.; Haga, N.; Mori, T.; Yamada, H.; Miura, I.; Tamaru, J.; Itoyama, S.; Ishida, H. 2010: The expression of thymidylate synthase (TS) and excision repair complementing-1 (ERCC-1) protein in patients with unresectable colorectal cancer treated with mFOLFOX6 therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2532-2535
Danenberg, P.V.; Malli, H.; Swenson, S. 1999: Thymidylate synthase inhibitors Seminars in Oncology 26(6): 621-631
Ishida, H.; Yamada, H.; Shirakawa, K.; Nakada, H.; Ohsawa, T.; Takeuchi, I.; Okada, N.; Yokoyama, M.; Inokuma, S.; Suzuki, T.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Itoyama, S.; Mori, T.; Matsumoto, Y.; Miura, T. 2003: Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1621-1626
Bavetsias, V.; Jackman, A.L. 1998: Nonpolyglutamatable antifolates as inhibitors of thymidylate synthase (TS) and potential antitumour agents Current Medicinal Chemistry 5(4): 265-288
Felczak, K.; Bretner, M.; Dzik, J.M.; Gołos, B.; Zieliński, Z.; Rode, W.; Kulikowski, T. 1998: N4-hydroxy-5-halogeno-2'-deoxycytidine S and their 5'-mono-phosphates as inhibitors of thymidylate synthase and in vitro antileukemic agents Advances in Experimental Medicine and Biology 431: 617-621
Springer, C.J.; Bavetsias, V.; Jackman, A.L.; Boyle, F.T.; Marshall, D.; Pedley, R.B.; Bisset, G.M. 1996: Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT) Anti-Cancer Drug Design 11(8): 625-636
Berglund, A.; Edler, D.; Molin, D.; Nordlinder, H.; Graf, W.; Glimelius, B. 2002: Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma Anticancer Research 22(6b): 3653-3659
Rode, W.; Balińska, M. 1985: Methionine synthase assay based on coupling with thymidylate synthase reaction Acta Biochimica Polonica 32(2): 163-167
Ishida, Y.; Kawakami, K.; Tanaka, Y.; Kanehira, E.; Omura, K.; Watanabe, G. 2002: Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer Anticancer Research 22(5): 2805-2809
Kawasaki, G.; Yoshitomi, I.; Yanamoto, S.; Yamada, S.-I.; Kawano, T.; Mizuno, A. 2010: Immunohistochemical and clinicopathological study of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase expression in oral cancer patients responding to UFT Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(6): 1035-1039
Rode, W.; Jarmuńa, A. 2015: Thymidylate synthase-catalyzed reaction mechanism Postepy Biochemii 61(3): 274-283
Ueda, T.; Dutschman, G.E.; Nair, M.G.; Degraw, J.I.; Sirotnak, F.M.; Cheng, Y.C. 1986: Inhibitory action of 10-deazaaminopterins and their polyglutamates on human thymidylate synthase Molecular Pharmacology 30(2): 149-153
Reilly, R.T.; Barbour, K.W.; Dunlap, R.B.; Berger, F.G. 1995: Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase Molecular Pharmacology 48(1): 72-79
Volm, M.; Sauerbrey, A.; Zintl, F. 1994: Dihydrofolate-reductase and thymidylate-synthase in childhood acute lymphoblastic leukemia Anticancer Research 14(3b): 1377-1381
Jones, T.R.; Betteridge, R.F.; Neidle, S.; Jackman, A.L.; Calvert, A.H. 1989: Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituent Anti-Cancer Drug Design 3(4): 243-248
Nair, C.P.; Noronha, J.M. 1991: An indirect role of vitamin B12 in regulation of thymidylate synthase in Lactobacillus leichmannii Indian Journal of Experimental Biology 29(12): 1112-1115